Skip to main content
Year archive

ACRUX LIMITED — 2026 filings

All 23 regulatory filings released by ACRUX LIMITED (ACR) in 2026, sourced directly from the official regulator.

23 Filings
2026 Period
2026 filings (23)
Filing Released Lang
Results of Meeting 2 pages 171.3KB
Regulatory Filings
2026-07-21 English
Application for quotation of securities - ACR 7 pages 19.6KB
Share Issue/Capital Change
2026-06-25 English
Notice of Extraordinary General Meeting/Proxy Form 30 pages 810.5KB
Proxy Solicitation & Information Statement
2026-06-15 English
Appendix 3Y Oldham 2 pages 237.7KB
Director's Dealing
2026-06-02 English
Appendix 3Y Dobinson 2 pages 196.6KB
Director's Dealing
2026-06-02 English
Appendix 3Y Brumley 2 pages 236.3KB
Director's Dealing
2026-06-02 English
Application for quotation of securities - ACR 7 pages 19.6KB
Share Issue/Capital Change
2026-06-02 English
Application for quotation of securities - ACR 5 pages 16.7KB
Share Issue/Capital Change
2026-06-02 English
Notification of cessation of securities - ACR 4 pages 14.7KB
Share Issue/Capital Change
2026-06-02 English
Update - Licensing Lenzetto for Australia for AUD5.4m 2 pages 147.8KB
Regulatory Filings
2026-05-28 English
Acrux licenses Lenzetto for Australian market for AUD5.4m 3 pages 191.3KB
Regulatory Filings
2026-05-27 English
Application for quotation of securities - ACR 6 pages 18.4KB
Share Issue/Capital Change
2026-05-17 English
Cleansing Notice 1
Share Issue/Capital Change
2026-05-17 English
Capital Gains Tax exemptions remain in place for Acrux 2 pages 147.1KB
Regulatory Filings
2026-05-13 English
Acrux raises $1.6 million via Share Placement 2 pages 173.7KB
Capital/Financing Update
2026-05-10 English
Proposed issue of securities - ACR 6 pages 22.1KB
Share Issue/Capital Change
2026-05-10 English
Trading Halt 2 pages 226.7KB
Capital/Financing Update
2026-05-06 English
Quarterly Activities/Appendix 4C Cash Flow Report 7 pages 333.6KB
Interim / Quarterly Report Q3 2026
2026-04-29 English
Acrux strategy focuses on Female Testosterone for low libido 20 pages 2.6MB
Investor Presentation
2026-04-27 English
Acrux receives $0.55m advance on FY26 R&D Tax Incentive 1
Capital/Financing Update
2026-03-11 English
Notification of cessation of securities - ACR 4 pages 14.7KB
Regulatory Filings
2026-02-25 English
Half Yearly Report and Accounts 19 pages 1.2MB
Interim / Quarterly Report H1 2026
2026-02-24 English
Quarterly Activities/Appendix 4C Cash Flow Report 7 pages 328.5KB
Interim / Quarterly Report Q2 2026
2026-01-28 English